Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated with improved clinical outcomes, supporting increased CYTOGAM utilization REHOVOT, Israel and…
Read the full articleYou might also wanna read
Citi Hosts AI Day for Secondary School Students in Hong Kong
Manila Times·2h ago
HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
Manila Times·2h ago
Benguet officials inspect CMDC exploration site amid Mankayan protest
Manila Times·2h ago
Duterte's satisfaction rating up in Q2 of 2026 – survey
Manila Times·2h ago
CCTV+: Hello, Beijing! A City Alive with Performing Arts
Manila Times·2h ago
Altinteg Strengthens Compliance-Ready Traceability For Food Operations
Manila Times·2h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.